The advent of digital pathology is expected to revolutionize the healthcare industry in China and help overcome challenges in medical education, clinical practices and research. Favorable government healthcare reforms, such as initiatives on nationwide telepathology consultation and quality control programs, as well as the growing need for integration of healthcare delivery will usher in a wave of digital pathology adoption in the country.
New analysis from Frost & Sullivan, Analysis of the Digital Pathology Market in China, finds that the market earned revenues of $259.0 million in 2013 and estimates this to rocket up to $1,914.8 million in 2019.
A burgeoning elderly population cohort the number of people over 60 years is projected to increase 8 million annually and reach 243 million by 2020 has heightened the need for accurate and reliable pathological diagnosis. The issue is further aggravated by a rising incidence of cancer across the country.
"With the escalating growth of digital data, leveraging advancements in information technology and big data analytics will shift future healthcare deliveries towards personalized, evidence-based treatments," said Frost & Sullivan Healthcare Research Analyst Raymond Chong. "Healthcare will revolve around collaboration among medical institutions with emphasis on predictive and preventive medicine, widening the potential of the Chinese digital pathology market."
Unfortunately, high investment and maintenance costs, low sample volume, and limited returns are hurdles to the use of digital pathology, particularly in rural regions. With barely 20 percent of medical resources allocated to rural areas, healthcare institutions remain reluctant to purchase these solutions.
Digital pathology system vendors in China should identify and understand targeted end-user segments and deliver cost-effective, customized solutions to sustain business viability. Implementing unique pricing strategies in which products and services are priced in line with customer budgets and expectations will enable manufacturers to retain market share.
"Digital pathology system vendors should seek partnerships with various participants along the value chain, including software vendors and device manufacturers," advised Chong. "Aligning investment plans with government and stakeholders' agenda to build long-term partnerships will further bolster their position in the fast-expanding Chinese market."
If you are interested in more information on this study, please send an email to Julie Zheng, Corporate Communications, at julie.zheng[.]frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.
Analysis of the Digital Pathology Market in China is part of the Connected Health (connectedhealth.frost.com) Growth Partnership Service program. Frost & Sullivan's related studies include: China Healthcare Information Technology Solutions Market, Global Enterprise Content Management (ECM) Market for Healthcare, US Market for General Wellness and Early Intervention Technologies, and Western and Eastern European Image and Information Management Systems Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation
Analysis of the Digital Pathology Market in China / P79C-48